Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Kevin Zhou's Sam Altman, published in November 2024, is a detailed portrait of the AI entrepreneur, from his early days as a ... ended up taking part. The biography offers contradictory views ...
was $540 now $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available until 27 February 2025.
The dispute between arguably the two biggest names in generative artificial intelligence—billionaires Sam Altman and Elon Musk—erupted this week after President Donald Trump announced a $500 ...
Sam Altman, CEO of OpenAI, has clarified that the company has not yet achieved Artificial General Intelligence (AGI), despite ...
OpenAI chief Sam Altman has ... It's not the first time Altman and Musk have publicly sparred with each other online. The pair have a history that goes back to OpenAI's early days.